Current stage?-Stage III - Page 9 of 33 Posts on Medivizor
Navigation Menu

Current stage?-Stage III Posts on Medivizor

Transanal endoscopic microsurgery after chemoradiotherapy improves rectal cancer outcomes

Transanal endoscopic microsurgery after chemoradiotherapy improves rectal cancer outcomes

Posted by on Feb 28, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated long term rectal cancer outcomes in patients who received chemotherapy, radiation therapy, and transanal microsurgery. Researchers suggested that this treatment improves treatment outcomes and quality of life of patients. Some background The standard treatment for rectal cancer is surgery. However,...

Read More

Looking for patients with advanced prostate cancer to test a type of radiation therapy

Looking for patients with advanced prostate cancer to test a type of radiation therapy

Posted by on Feb 22, 2019 in Prostate cancer | 0 comments

In a nutshell This trial evaluates a specific type of radiation therapy for advanced prostate cancer. The main outcome to be measured is whether or not the therapy will damage the surrounding organs. This trial is taking place in Pennsylvania, USA.  The details Prostate cancer is an uncontrolled growth of the cells which make up the...

Read More

Chemotherapy and radiation therapy are safe options before surgery in elderly patients with rectal cancer

Chemotherapy and radiation therapy are safe options before surgery in elderly patients with rectal cancer

Posted by on Feb 13, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of chemotherapy and radiation therapy (CRT) with capecitabine (Xeloda) before surgery in elderly patients with locally advanced rectal cancer. Researchers suggested that this treatment is safe and well tolerated in the elderly. Some background Colorectal cancer is the third most commonly...

Read More

Joint pain and falls among women with breast cancer on aromatase inhibitors.

Joint pain and falls among women with breast cancer on aromatase inhibitors.

Posted by on Jan 18, 2019 in Breast cancer | 0 comments

In a nutshell This study wanted to find out if joint pain is associated with falling down in patients with breast cancer who were treated with aromatase inhibitors. The study found that the patients who reported having joint pain were more likely to have a fall than those who had no joint pain. Some background Aromatase inhibitors are medications...

Read More

Adding everolimus to endocrine therapy in patients with HER2- ER+ advanced breast cancer

Adding everolimus to endocrine therapy in patients with HER2- ER+ advanced breast cancer

Posted by on Jan 5, 2019 in Breast cancer | 0 comments

In a nutshell This study wanted to find out if treating breast cancer with everolimus (Afintor) and endocrine therapy is better than only treating with endocrine therapy. The study found that using everolimus in addition to endocrine therapy had a significant benefit to survival in these patients. Some background Breast cancer is classified into types...

Read More

Adding ixabepilone to capecitabine treatment for triple negative breast cancer.

Adding ixabepilone to capecitabine treatment for triple negative breast cancer.

Posted by on Dec 11, 2018 in Breast cancer | 0 comments

In a nutshell This study wanted to find out if ixabepilone (Ixempra) and capecitabine (Xeloda) work for treating triple-negative breast cancer in patients with hard to treat disease compared to using capecitabine alone. The study found that adding ixabepilone to treatment resulted in longer survival without the cancer progressing. Some background...

Read More

Erlotinib in patients with non-small cell lung cancer

Erlotinib in patients with non-small cell lung cancer

Posted by on Dec 11, 2018 in Lung cancer | 0 comments

In a nutshell This study wanted to find out if using the medication erlotinib (Tarceva) in patients with non-small cell lung cancer improved survival. The study found that using erlotinib was safe, and may reduce the need for radical surgery in patients with non-small cell lung cancer. Some background Epidermal growth factor receptor (EGFR) is...

Read More

Apalutamide does not affect health-related quality of life in patients with localized prostate cancer

Apalutamide does not affect health-related quality of life in patients with localized prostate cancer

Posted by on Nov 28, 2018 in Prostate cancer | 0 comments

In a nutshell This study investigated the effect of apalutamide (Erleada) on health-related quality of life (H-QoL) in patients with prostate cancer. This study found that apalutimide preserved H-QoL while prolonging time taken for cancer to spread.  Some background One treatment option for patients with prostate cancer is androgen...

Read More

Is conventional or hypofractionated radiation therapy better for the treatment of prostate cancer?

Is conventional or hypofractionated radiation therapy better for the treatment of prostate cancer?

Posted by on Nov 26, 2018 in Prostate cancer | 0 comments

In a nutshell This study compared two different types of radiation therapy after prostate surgery for prostate cancer, hypofractionated postprostatectomy radiation therapy (hypoPORT) and conventional postprostatectomy radiation therapy (coPORT). Results showed that hypoPORT may be effective in prostate cancer control and with similar side effects as...

Read More